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In recent years there has been a marked rise in the frequency of
young people engaging in self-harm.1 Identifying those who are
at risk is important because every episode of self-harm increases
the risk of future episodes2 and, eventually, of suicide.3 In this
paper the term ‘self-harm’ includes self-poisoning, with or without
suicidal intent.4 The risk of self-harm increases when multiple risk
factors are present.2 The presence of a severe psychiatric disorder
such as major depression is among the strongest predictors of self-
harm.5 Anxiety, especially if acute and intense, also has an important
role.6 In addition to anxiety, patients who self-harm describe feelings
of chronic emptiness, alienation and isolation.7 In the context of
these unpleasant experiences, they report thoughts of hopelessness,8
helplessness,9 of being a burden to loved ones,10 of unlovability and
poor distress tolerance,11 and of low self-esteem.12 Poor problem-
solving ability is assumed to interact with suicidal cognitions,
increasing the risk of self-harm.13
Although in-patient treatment is the standard of care for
people who self-harm, it has never been found efficacious in a
controlled clinical trial.14 Furthermore, controlled cognitive–
behavioural therapy (CBT) intervention studies for self-harm
are limited and their results are inconsistent. Tyrer et al reported
that brief CBT is no more effective than usual care when it comes
to preventing repetition of self-harm,15 whereas Brown et al
reported positive effects of cognitive therapy on suicide attempts,
depression and hopelessness.16 In addition, several controlled
studies have established the efficacy of dialectical behavioural
therapy in reducing self-injury in (female) patients with border-
line personality disorder.17 Schema-focused therapy has also been
found to reduce self-harm effectively in patients with borderline
personality disorder.18 Furthermore, cognitive–behavioural
interventions with a problem-solving component seem to have
positive effects on self-harm.19 These findings are important, given
the strong association between acts of self-harm and the risk of
suicide described above. In addition, given the association
between negative emotions, suicidal cognitions, problem-solving
deficits and self-harm, it is important to assess in more detail
the impact of treatment on these correlates of self-harm.
In the study reported here the efficacy of a short, manualised
cognitive–behavioural intervention for self-harm was investigated.
This intervention was based on a cognitive–behavioural model of
maintenance factors of self-harm.20 The model assumed that
vulnerability to self-harm can be changed by changing suicidal
and negative thinking and problem-solving deficits. The inter-
vention aimed to develop cognitive and behavioural skills for
coping with situations that trigger self-harm. Considering the
wide range of psychiatric, psychological and social problems that
patients present with, the intervention was intended to give
therapists a clear framework to orient themselves within the
therapy. At the same time, the intervention needed to be flexible
enough to be of help to a broad range of patients, including those
with high risk of repetition of self-harm and high levels of psy-
chiatric comorbidity. The study was designed to determine the
short-term and long-term efficacy of the intervention with respect
to the rate of repetition of self-harm as well as emotional
problems, suicidal cognitions and problem-solving deficits. It
was predicted that the rate of self-harm of participants who
received CBT in addition to treatment as usual (TAU) would be
lower than in patients who received TAU only, and also that par-
ticipants from the CBT condition would have significantly lower
scores for emotional problems (depression and anxiety) and suicidal
cognitions, and significantly higher scores for functional cognitions
(self-esteem) and behavioural skills (problem-solving ability)
following treatment, than participants from the TAU condition.
Method
Participants
Patients aged 15–35 years were included in the study if they
had recently engaged in self-harm, defined as both deliberate
self-poisoning (overdose) and self-injury.4 Patients were excluded
if they reported a severe psychiatric disorder (e.g. schizophrenia)
requiring intensive in-patient treatment (as assessed during the
baseline interview with a structured diagnostic interview: the Mini
International Neuropsychiatric Interview (MINI)),21 were unable
to converse in Dutch, had cognitive impairments or lived outside
the region of Leiden.
202
Cognitive–behavioural intervention for self-harm:
randomised controlled trial
Nadja Slee, Nadia Garnefski, Rien van der Leeden, Ella Arensman and Philip Spinhoven
Background
Self-harm by young people is occurring with increasing
frequency. Conventional in-patient and out-patient treatment
has yet to be proved efficacious.
Aims
To investigate the efficacy of a short cognitive–behavioural
therapy intervention with 90 adolescents and adults who had
recently engaged in self-harm.
Method
Participants (aged 15–35 years) were randomly assigned to
treatment as usual plus the intervention, or treatment as
usual only. Assessments were completed at baseline and at
3 months, 6 months and 9 months follow-up.
Results
Patients who received cognitive–behavioural therapy in
addition to treatment as usual were found to have
significantly greater reductions in self-harm, suicidal
cognitions and symptoms of depression and anxiety, and
significantly greater improvements in self-esteem and
problem-solving ability, compared with the control group.
Conclusions
These findings extend the evidence that a time-limited
cognitive–behavioural intervention is effective for patients
with recurrent and chronic self-harm.
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The study was conducted at the Leiden University Medical
Centre and the Rivierduinen mental health centre from March
2003 until April 2006. The initial sample consisted of 222 individ-
uals who had visited the Leiden University Medical Centre or the
local mental health centre because of self-harm. Of these 222
people, 32% (n=72) could not be reached, because the name,
address or telephone number they had left was incorrect. Of the
68% (n=150) who were contacted, 12% (n=26) declined to parti-
cipate and 11% (n=24) were excluded from the study. Reasons for
exclusion were the index episode not being an act of self-harm
(n=3), being under 15 years old (n=1), being hospitalised for an
extended period because of schizophrenia or alcohol or drug
misuse (n=11), being unable to converse in Dutch (n=3), having
cognitive impairments (n=2) or living abroad (n=4). As a result,
100 individuals (45% of the initial sample) were invited for the
baseline interview. The flow of these participants through the
study is illustrated in Fig. 1. It shows that 10 people failed to meet
the inclusion criteria: they were unable to converse in Dutch
(n=2), had cognitive impairments (n=1) or were living outside
the Leiden area (n=5). Two more persons did not want to com-
plete the baseline interview. The 90 individuals who entered the
study were randomly assigned to 12 CBT sessions in addition to
TAU (n=48) or to TAU only (n=42).
Of the 48 people who were randomly assigned to the CBT
condition, 8 (17%) left the study prior to the first session (just
after the baseline interview), leaving 40 participants to enter
treatment. All 40 participants who entered CBT completed the
12 sessions of therapy, as well as the three follow-up assessments.
Reasons for leaving the study just after the baseline interview were
‘not wanting to be in therapy’ (n=4), having started an alternative
treatment (n=1), having moved (n=2) or having run away from
home (n=1). Of the 42 participants who were randomly assigned
to the TAU condition, 5 (12%) did not complete the 3-month
follow-up interview, owing to severe psychiatric disorder (n=2),
having moved out of the region (n=1), being sentenced to prison
(n=1) or reportedly being too busy (n=1). Three more partici-
pants did not complete the 6-month follow-up interview, owing
to severe psychiatric disorder (n=1), no longer wishing to partici-
pate in the project (n=1) or having died by suicide (n=1). One
person did not complete the 9-month follow-up interview because
she had died by suicide, bringing the total leaving the study to 9
persons (21%). Participants completing and leaving the study
did not differ demographically, on history of self-harm or on
any of the outcome variables at baseline.
Procedure
On visiting one of the participating centres, individuals who had
recently engaged in self-harm received a brochure with a complete
description of the study. In this brochure it was announced that
the person would be contacted by a member of the research team,
who would provide further information on the study and would
ask if the person were interested in participating. Informed con-
sent was obtained from all participants, and from parents of
adolescents below the age of 16 years. After participants had given
written consent they were interviewed in their home or at the
medical centre. We allowed a week to pass between a person’s
index episode of self-harm and entering the study, 2 weeks to pass
between the index episode and the initial interview, and 3 weeks
between the index episode and the first session of CBT. Those
who agreed to participate and were found to be eligible for the
study were randomly assigned to 12 sessions of CBT in addition
to TAU, or to TAU only. All participants were invited for
subsequent assessments 3 months, 6 months and 9 months follow-
ing the baseline interview. Like the baseline interviews, these
interviews were conducted in the participant’s home or at the
medical centre. The medical ethics committee of the Leiden Uni-
versity Medical Centre approved all procedures.
Design
Participants were randomly assigned to 12 sessions of CBT in
addition to TAU (n=48) or to TAU only (n=42). Randomisation
to treatment was accomplished using a computer program and a
random-number generator provided by an independent investiga-
tor. Stratification was not used. Although masked assessments
were conducted at baseline, masking of follow-up assessments
was not possible because participants were asked about their use
of healthcare services at each assessment. In addition, information
regarding treatment assignment was essential to provide care for
individuals who were in crisis. The assessments were conducted
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Assessed for eligibility
n=100
Randomised
n=90
CBT
n=48
Treatment as usual
n=42
Received allocated
intervention
n=40
Received allocated
intervention
n=42
Follow-up assessment
n=40
Follow-up assessment
n=33
Analysis n=40
(excluded from analysis,
n=8)
Analysis
n=42
Excluded n=10
Unable to converse
in Dutch (n=2)
Cognitive impairment
(n=1)
Living outside the
region of Leiden (n=5)
Not wanting to
complete interview
(n=2)
Did not receive
allocated intervention
n=8
Did not want to be
in therapy (n=4)
Chose an alternative
treatment (n=1)
Moved (n=2)
Ran away from home
(n=1)
Lost to follow-up n=9
Suicide (n=2)
Severe psychological
problems (n=3)
Moved (n=1)
Sentenced to prison
(n=1)
Too busy (n=2)
Fig. 1 Flow of participants through the study (CBT, cognitive–
behavioural therapy).
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by an independent member of the research team who was not the
participant’s therapist.
Outcome measures
The primary outcome measure of the study was the number of
episodes of self-harm in the past 3 months, which was assessed
using a structured clinical interview. Self-harm was defined as in-
cluding both deliberate self-poisoning (overdose) and self-injury.4
An overdose was defined as the deliberate ingestion of more than
the prescribed or recommended amount of a chemical substance
with the intention of self-harm. Patients were also asked about
incidents of self-injury, which was defined as intentional self-
injury irrespective of the apparent purpose of the act, and in-
cluded cutting, scratching, punching, kicking and head-banging.
In this definition, both the original parasuicide definition of the
World Health Organization (WHO)/Euro study and that study’s
current nomenclature of fatal and non-fatal suicidal behaviour
are included, as well as habitual behaviours and self-injuries with
no intent to die, which the WHO/Euro study excluded.22,23 Thus,
all behaviour that was self-initiated with the intent to harm the
body (regardless of intent to die) was included.
At each of the four assessments participants were asked about
the number of episodes of self-harm in the past 3 months. Other
aspects of self-harm were also recorded: suicide intent, motives,
the antecedent events and consequences. However, only the num-
ber of episodes of self-harm was selected as the primary outcome
measure. To investigate the reliability of the assessment of the
number of episodes of self-harm, the retrospective self-reports
were compared with hospital records, as well as with information
coming from the treatment sessions. The correlations between the
three measures were high, with correlations ranging from 0.88 to
0.90. Scores of the number of episodes of self-harm in the past 3
months ranged from 0 to 25.
Secondary outcome measures assessed by patient self-report at
the baseline, 3-month, 6-month and 9-month assessments in-
cluded depression, anxiety, self-esteem, suicidal cognitions and
problem-solving ability.
Depression
Depression was measured with the Beck Depression Inventory II
(BDI–II),24,25 a 21-question depression scale with each answer
rated 0–3. Scores range from 0 to 63. The test has high internal
consistency, with a=0.91.24,26 In this study we found a reliability
of a=0.93.
Anxiety
Anxiety was measured using a sub-scale of the Symptom
Checklist–90,27,28 which is a self-report clinical rating scale of
psychiatric symptoms. The ‘anxiety’ sub-scale consists of ten
items, assessing whether and to what extent participants reported
symptoms of anxiety. Items are measured on a five-point Likert
scale, ranging from ‘not at all distressing’ (0) to ‘extremely distres-
sing’ (4). Individual sub-scale scores are obtained by summing the
ten items (range 0–40). Previous studies have reported alpha co-
efficients ranging from 0.71 to 0.91 for the anxiety sub-scale. In
addition, test–retest reliabilities are found to be good and the
sub-scale has been found to show strong convergent validity with
other conceptually related scales.28 In our study we found a
reliability of a=0.93 for the anxiety sub-scale.
Self-esteem
Self-esteem was measured with the Robson Self-Concept Ques-
tionnaire, Short version,29 an eight-item questionnaire dealing
with attitudes and beliefs that people have about themselves, for
example, ‘I’m glad I am who I am’. All items are self-rated from
1 to 4 (‘strongly disagree’ to ‘strongly agree’). Scores range from
8 to 32. The scale has good validity and reliability;29 in our study
we found a reliability of a=0.82.
Suicidal cognition
Suicidal cognitions were measured using the Suicide Cognition
Scale.11 This comprises 20 questions about core beliefs of
perceived burdensomeness (‘I am a burden to my family’), help-
lessness (‘no one can help solve my problems’), unlovability (‘I
am completely unworthy of love’) and poor distress tolerance
(‘when I get this upset, it is unbearable’), with each answer rated
1 (strongly disagree) to 5 (strongly agree). Scores on the total scale
range from 20 to 100. Scores on the perceived burdensomeness
sub-scale (two items) range from 2 to 10, scores on the helpless-
ness sub-scale (five items) range from 5 to 25, scores on the
unlovability sub-scale (six items) range from 6 to 30 and scores
on the poor distress tolerance sub-scale (seven items) range from
7 to 35. In this study we found alpha reliability values of 0.96 for
the total scale, 0.74 for perceived burdensomeness, 0.88 for help-
lessness, 0.90 for poor distress tolerance and 0.89 for unlovability.
Problem-solving
Problem-solving ability was measured with the Coping Inventory
for Stressful Situations (CISS) sub-scale task ‘oriented coping’.30
This sub-scale consists of 16 items scored on a five-point Likert
scale, referring to the extent to which people make use of
problem-solving techniques in the face of stress (‘Make an extra
effort’) with answers ranging from 1 (‘not at all’) to 5 (‘very
strongly’. Scores range from 16 to 80. Across studies, the CISS
has proved to be reliable. The internal consistency of the sub-
scales is excellent (a40.85).30,31 In this study we found a reliabil-
ity of a=0.93.
Other measures
Demographic information was obtained, as well as information
about the use of healthcare services. Baseline characteristics also
included suicide intent and motives of the index episode of self-
harm. Suicide intent was assessed with the Suicide Intent Scale
(SIS),32 an instrument with sound psychometric properties. The
SIS has 20 items, but only the first 15 items are used for cal-
culating the score. Scoring for each item ranges from 0 to 2. Items
1–9 are concerned with the act itself, items 10–15 with the
thoughts and feelings associated with the act, and items 16–20
with the respondent’s thoughts and feelings about suicide in the
present. To assess motives for self-harm, the Reasons for Overdose
Scale was used.33 The ten motives presented were a subset of those
originally developed by Bancroft et al,34 including wanting to die,
wanting to get relief and wanting to escape. Participants were
asked to indicate the extent to which these motives were important
to them at the time of the index episode.
Psychiatric diagnosis
For screening purposes, psychiatric diagnosis was assessed
using a short structured diagnostic interview with an admin-
istration time of approximately 20–30 min, the MINI.21 In this
study the Dutch translation of the clinician-rated version of the
MINI was used (MINI–CR).35 Validation of the MINI–CR against
the Structured Clinical Interview DSM–III–R Patient version and
the Composite International Diagnostic Interview for ICD–10
showed good to very good kappa values.21
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Intervention
Cognitive–behavioural therapy
In addition to usual care (e.g. prescribed psychotropic medication,
psychotherapy, psychiatric hospitalisations), participants in the
CBT condition received 12 out-patient CBT sessions specifically
developed for preventing self-harm. The sessions were provided
on a weekly basis or as needed in case of crisis. Ten of the 12
sessions were given weekly; the last two were follow-up sessions.
All together, the intervention lasted approximately 5.5 months.
The central feature of this intervention was the identification
and modification of the mechanisms that maintained self-harm.
Thus, the treatment started with the assessment of the most recent
episode of self-harm (e.g. circumstances at the time of the episode,
motives and reasons for self-harm, cognitions, emotions and
behaviour prior to and at the time of the episode). The therapist
and patient then investigated how emotional, cognitive and behav-
ioural factors played a part in the maintenance of self-harm.
Specific maintenance factors that were addressed included dys-
functional cognitions, emotion regulation difficulties and poor
problem-solving. Near the end of therapy relapse prevention
was addressed as well. The treatment is first and foremost an indi-
vidual one. However, involvement of the partner or (non-abusive)
parents in the therapeutic process is of great importance, since
these patients need the support of others to overcome self-harm.
A manual was written to standardise the intervention (available
from the authors upon request). To improve treatment compliance,
therapists played an active part in keeping patients in treatment
(e.g. calling patients to remind them of appointments).
All therapists were experienced practitioners of CBT and
accustomed to working with patients who engage in self-harm.
Before they took part in the research project, the therapists
received 2 days of training in the standardised protocol. To maintain
the integrity of treatment, the therapists followed this treatment
protocol. In addition, checklists and outlines were used in every
session to foster correct execution of the treatment. At monthly
meetings the treatment sessions were reviewed and therapists
could share their experiences with their colleagues. Issues that
were discussed were reactions in the therapist elicited by episodes
of self-harm (e.g. sadness, worry, aversion) or problems with treat-
ment compliance. The average number of patients treated by each
of the therapists was eight (range seven to nine).
Treatment as usual
For ethical reasons participants in both study conditions were free
to pursue any form of usual treatment they deemed warranted. We
recorded three forms of TAU: psychotropic medication, psycho-
therapy and psychiatric hospitalisations. In addition, we recorded
whether psychotherapy in TAU had a focus on self-harm. How-
ever, we did not systematically record the specific types of
psychotherapy or psychotropic medication that patients in the
comparison condition received, nor did we record the specific
types of psychotherapy or psychotropic medication those in the
experimental condition received in addition to the intervention
therapy. As a result, we do not know whether the comparison
group and experimental group were equivalent in this respect.
Although we did not systematically record specific types of
psychotherapy in TAU, most of the interventions involved a lim-
ited number (2–30) of sessions of individual psychotherapy such
as CBT and interpersonal psychotherapy. Social skills training
was also common, especially among adolescents and young adults.
No treatment specific to self-harm was reported. These treatments
focused instead on specific psychiatric problems (e.g. depression)
or on specific needs of the patient (e.g. problems with housing,
finances, social isolation).
Statistical procedure
The study design was constrained to a maximum of four measure-
ments per participant. Given this restriction, a power analysis was
performed to determine the sample size needed to detect between-
group differences on the primary outcome measure – the number
of episodes of self-harm. Results obtained with the program
PINT36 indicated that a sample size of approximately 45 parti-
cipants in each group would be sufficient to detect a difference
in average time slope between the groups of 0.40 (corresponding
to a small effect size) with adequate power (0.80) and a=0.05.
Socio-demographic characteristics and outcome measures of the
groups were examined using t-tests or chi-squared tests, as appro-
priate. Multilevel analysis was used to analyse the development of
each outcome measure over time; this procedure is especially
suited to analysing repeated-measure data because it takes into
account the dependencies among observations nested within indi-
viduals. Another advantage of this method is its ability to handle
missing data, which is also common to the type of longitudinal
research discussed in this paper. Random coefficient models were
fitted for all outcome measures, allowing for individual variation
of intercepts and regression slopes. (In all models time was
included as a variable with values 0, 3, 6 and 9. Condition, medi-
cation use, psychotherapy and suicidal acts were all included as
dummy variables: TAU 0, CBT 1; no medication 0, medication
use 1; no psychotherapy 0, psychotherapy 1; no suicidal act 0,
suicidal act 1.) Fixed effects of time, condition and the interaction
between time and condition were tested using two-tailed z-tests.
Effects of baseline differences with regard to suicidal acts during
the past 3 months on the development of all outcome measures
over time were controlled for (suicidal acts condition time).
Effects of baseline use of psychotropic medication and psycho-
therapy on the development of all outcome measures over time
were also controlled for: medication use6condition6time and
psychotherapy6condition6time. Models were fitted using
MLwiN version 2.02.37 In addition, effect sizes were calculated
to facilitate comparison of improvement in the CBT condition
with improvement in the TAU condition. Effect sizes were derived
by calculating the difference of the means on the outcome variables
in CBT and TAU at the 3-month, 6-month or 9-month assessment,
divided by the pooled standard deviation (see reference 38 for the
program to calculate effect sizes). Furthermore, to give an
indication of the differences between the conditions for a given vari-
able at baseline, 3-month, 6-month and 9-month assessments,
significance levels were calculated using t-tests or chi-squared tests.
Results
Demographic characteristics, psychiatric diagnosis and history of
self-harm for participants in the two study groups are reported
in Table 1 and online Table DS1. There was no significant differ-
ence between the CBT group (n=40) and the TAU group (n=42)
on any of the demographic characteristics including gender, age,
living situation, marital status, educational level, job status or
nationality (Table 1). In addition, no significant difference was
found with regard to psychiatric comorbidity, history of previous
episodes of self-harm, self-mutilation in the past 3 months or rate
of leaving the study (online Table DS1). However, there was a
trend towards more suicidal acts in the past 3 months in the
TAU group at baseline (t=–1.91, d.f.=1, n=82; P=0.06), and this
variable was included in the multilevel analysis models. The base-
line table also includes information on the nature of the index
episode of self-harm in both groups. The majority of the
participants reported self-poisoning at index (CBT 87%, TAU
91%; not significant). Suicide intent and motives at index did
205
Slee et al
not differ significantly between the groups (online Table DS1). We
also investigated whether the groups differed significantly on use
of healthcare services: there was no significant baseline difference,
except for trends towards more medication use in the TAU group
at baseline (w2=3.12, d.f.=1, n=82; P=0.08) and trends towards
more psychotherapy in the TAU group at baseline (w2=4.74,
d.f.=1, n=82; P=0.09). Both medication use and psychotherapy
at baseline were included in the multilevel analysis models. Psychi-
atric hospitalisation was not included as a covariate in the models
because this had not been reported at baseline (Table 2 and online
Table DS2). In addition, we used multilevel analysis to determine
whether there was any baseline difference between the groups on
the primary and secondary outcome measures (see ‘condition’
effects in Table 3 and online Tables DS3 and DS4). No significant
group difference was found on any of these outcome measures
(Table 3 and online Tables DS3 and DS4). The mean number of
episodes of self-harm during the past 3 months as reported at
baseline was 14.42 (s.d.=10.51) in CBT and 11.62 (s.d.=11.42) in
TAU; score range 0–25 (Table 2 and online Table DS2).
Primary and secondary outcome measures
Table 2 shows the means and standard deviation of scores on the
primary and secondary outcome measures at baseline and at the
3-month, 6-month and 9-month assessments, including signifi-
cant group differences based on t-tests. In addition, it shows that
during the study period two persons in the TAU group died by
suicide. The online Table DS2 describes the use of healthcare
services by patients in CBT and TAU and group differences based
on chi-squared tests.
Outcome of treatment at 9 months
In Table 3 (multilevel analysis without the 8 early withdrawals,
n=82), online Table DS3 (multilevel analysis with those complet-
ing the intervention, n=73) and online Table DS4 (multilevel
analysis with intent-to-treat sample, last observation carried
forward, n=90), fixed effects and corresponding standard errors
are reported for the multilevel analysis models regarding the
primary and secondary outcome measures. (In multilevel analysis
the most commonly used estimation method is maximum likeli-
hood. For this method it is necessary to assume normality for the
dependent variable. The distribution of self-harm does not satisfy
the normality assumption. However, all conclusions are based on
the interpretation of fixed effects. Simulation results show that with
the sample size in this study estimates of fixed effects and their
standard errors are not seriously affected by non-normality of the
residuals.39,40 Moreover, a comparison between the maximum like-
lihood standard errors and the so-called ‘robust standard errors’,
used as a tool to assess model mis-specifications, showed that results
for self-harm can be considered reliable and can be interpreted cor-
rectly.) The effect of ‘time’ indicates the overall increase or decrease
for each of the outcome measures. The effect of ‘condition’ indicates
the difference between CBT and TAU at baseline. The interaction
effect (time6condition) indicates whether there is a significant
difference between CBT and TAU upon the development of the
outcome measures over time. To control for baseline differences
in suicidal acts during the past 3 months, the interaction of
suicidal acts6condition6time was included in the models as
well. In addition, to control for baseline differences in psychotro-
pic medication use and psychotherapy, the interactions of medi-
cation use6condition time and of psychotherapy6condition
time were included in the models. Fixed effects were tested by
two-tailed z-tests. Variance components are omitted here because
they are not the primary focus of our study.
Multilevel analysis results without the 8 participants who left
the study early (n=82; Table 3) showed that overall self-harm,
depression and suicidal cognitions (total scale and the sub-scales
perceived burdensomeness, poor distress tolerance and unlovabil-
ity) significantly decreased over time. Self-esteem was shown to
increase significantly over time. No significant effect was found
for ‘condition’, indicating that on average there was no significant
baseline difference between the groups on all outcome measures.
The fixed effects of time6condition showed that there was a
significant effect of condition upon the development (increase
or decrease) of all outcome measures over time. For instance,
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Table 1 Demographic characteristics of participants receiving cognitive–behavioural therapy (n=40) and treatment as usual (n=42)
Statistical test P
Gender
CBT 97% female w2=1.77 0.18
TAU 91% female
Age, years
CBT Mean 23.9 (s.d.=6.4) t=71.18 0.24
TAU Mean 25.4 (s.d.=4.5)
Living situation
CBT 73% live alone, 27% live together w2=1.07 0.59
TAU 74% live alone, 26% live together
Marital status
CBT 73% unmarried, 8% married, 17% widowed, 2% divorced w2=4.35 0.36
TAU 78% unmarried, 5% married, 10% widowed, 7% divorced
Educational level
CBT Primary school 27%, secondary school 34%, lower education 13%, higher education/university 25% w2=12.41 0.13
TAU Primary school 19%, secondary school 35%, lower education 25%, higher education/university 21%
Job status
CBT 38% go to school/study, 25% have full-time or part-time job, 37% live on social security w2=11.84 0.34
TAU 19% go to school/study, 27% have full-time or part-time job, 36% live on social security
Nationality
CBT 90% Dutch, 5% other European, 5% Turkish/Moroccan w2=7.08 0.42
TAU 93% Dutch, 5% other European, 2% Turkish
CBT, cognitive–behavioural therapy; TAU, treatment as usual.
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the estimated value of –0.576 in the model for self-harm indicates
that the individuals in the CBT group, on average, showed a
significant difference in decrease of self-harm compared with
individuals in the TAU group (Table 3). The significant time6
condition effects remain with different ways of handling study
withdrawals. Multilevel analysis results using the ‘completers’ sam-
ple (n=73; online Table DS3) and the last observation carried for-
ward (LOCF) method (n=90; online Table DS4) showed a slightly
smaller effect for ‘time’ on average, but a similar significant effect
for time6condition as multilevel analysis without the 8 early
withdrawals (n=82, see Table 3). The most conservative analysis
(LOCF) showed the strongest effect for CBT on self-harm
(t=72.843), whereas the more optimistic analysis without the 8
early withdrawals showed the weakest effect for CBT on self-harm
(t=72.390). However, each of the three analyses led to the same
significant effect of time6condition. Moreover, none of the effects
of suicidal acts during the past 3 months6condition6time were
significant, indicating that there was no effect of suicidal acts at
baseline on the development of the outcome measures over time
in the two conditions. In addition, none of the effects of
medication use6condition6time was significant, indicating that
there was no effect of medication use at baseline on the develop-
ment of the outcome measures over time in the two conditions.
Furthermore, none of the effects of psychotherapy6condition6
time was significant, indicating that there was no effect of
psychotherapy at baseline on the development of the outcome
measures over time in the two conditions. These interaction
effects are omitted from the models. Table 3 (multilevel analysis
without the 8 early withdrawals, n=82), online Table DS3
(multilevel analysis with completers, n=73) and online Table
DS4 (multilevel analysis with LOCF, n=90) present the results of
a simple model with only three fixed effects, which is preferable
because it is easier to understand. In addition, effect sizes were
calculated to facilitate comparison of improvement in the CBT
condition with improvement in the TAU condition (Table 3 and
online Tables DS3 and DS4). Effect sizes of 0.20 indicate small
effects, effect sizes of 0.50 indicate medium effects, whereas values
of 0.80 indicate large effects.41 As can be derived from Table 3 and
online Tables DS3 and DS4, the effect sizes become larger during
the follow-up period and at the 9-month assessment effect sizes
are medium for the difference in self-harm and large to very large
for the differences on all other primary and secondary outcome
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Table 2 Primary and secondary outcome measures at baseline and follow-up (n=82)
Baseline 3 months 6 months 9 months
CBT/TAU, n 40/42 40/37 40/34 40/33
M (SD) M (SD) M (SD) M (SD)
Primary outcome measurea
Self-harm episodes in past 3 months, mean (s.d.)
CBT 14.42 (10.51) 5.63 (9.04) 5.30 (9.44) 1.18 (4.22)*
TAU 11.62 (11.42) 5.65 (9.24) 4.03 (7.16) 4.58 (8.37)
Suicide in past 3 months, n
CBT 0 0 0 0
TAU 0 0 1 1
Secondary outcome measures, mean (s.d.)a
Depression (BDI–II)
CBT 31.35 (12.85) 21.15 (13.48)* 16.58 (13.70)** 11.58 (12.12)**
TAU 34.67 (14.01) 30.08 (18.63) 28.56 (18.62) 29.61 (17.51)
Anxiety (SCL–90)
CBT 30.60 (8.67) 24.95 (9.02) 24.20 (8.14) 19.78 (7.70)**
TAU 28.05 (10.51) 28.78 (12.00) 29.03 (11.57) 27.36 (11.08)
Self-esteem (RSCQ)
CBT 16.38 (3.24) 18.13 (4.35) 19.15 (3.71)* 20.58 (4.36)**
TAU 15.38 (4.46) 16.11 (5.65) 16.85 (5.56) 16.70 (5.10)
Suicide cognition (SCS)
CBT 58.33 (14.86) 46.63 (16.56)* 42.48 (19.67)* 36.60 (17.05)**
TAU 63.29 (19.47) 59.70 (24.48) 56.26 (22.50) 54.88(19.05)
Perceived burdens (SCS)
CBT 6.65 (2.01) 4.98 (2.41) 4.75 (2.67)* 3.88 (2.03)**
TAU 6.88 (2.33) 6.24 (2.82) 6.21 (2.57) 5.76 (2.35)
Helplessness (SCS)
CBT 15.85 (4.97) 12.90 (4.78)* 11.95 (5.90)** 10.38 (4.80)**
TAU 17.55 (5.83) 17.11 (7.36) 16.32 (6.79) 15.97 (5.25)
Poor distress tolerance (SCS)
CBT 19.38 (5.33) 15.13 (5.92)* 13.65 (6.61)* 11.65 (5.73)**
TAU 20.88 (6.29) 19.24 (7.84) 18.09 (7.88) 17.52 (6.77)
Unlovability (SCS)
CBT 16.45 (5.21) 13.63 (5.56) 12.13 (6.14)* 10.70 (5.56)**
TAU 17.98 (6.14) 17.11 (7.40) 15.64 (6.50) 15.64 (5.90)
Problem-solving (CISS)
CBT 27.00 (10.42) 31.18 (11.05) 32.55 (11.66) 36.25 (11.50)**
TAU 25.76 (13.45) 26.97 (13.19) 25.70 (13.99) 26.24 (13.13)
BDI–II, Beck Depression Inventory II; CISS, Coping Inventory for Stressful Situtations; RSCQ, Robson Self-Concept Questionnaire (short version); SCL–90, Symptom Checklist–90; SCS,
Suicide Cognition Scale.
a. Significance calculated using t-tests.
b. Significance calculated using w2-test.
*P50.05, **P50.01.
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measures between both treatment conditions. The use of para-
metric statistics with skewed data (the number of episodes of
self-harm) might have reduced the effect size estimates as
presented in Table 3 and online Tables DS3 and DS4.
Visual inspection of means in Table 2 and effect sizes in Table 3
and online Tables DS3 and DS4 suggests a curvilinear time trend for
self-harm in TAU but a linear trend for self-harm in CBT. However,
the curvilinear trend did not prove to be significant. We therefore
used a linear model for self-harm in CBT as well as TAU.
Use of healthcare services during the study period
Chi-squared tests were used to examine differences in the use of
healthcare services during the study period. Table 2 shows that
at baseline, 43% (n=17) of the patients in the CBT group received
psychotherapy. About half of these patients preferred to interrupt
their regular psychotherapy schedule for a period of 3 months,
which was the period in which 10 out of 12 CBT sessions took
place. Between baseline and the 3-month assessment, only 21%
of the patients received CBT for self-harm and regular psycho-
therapy at the same time. Between the 3-month and 6-month
assessments, 28% of the patients received CBT for self-harm in
addition to usual care (Table 2). After the CBT intervention,
52% (n=25) of the patients continued or began regular
psychotherapy. Table 2 also shows that individuals receiving
CBT used significantly less psychotropic medication between the
baseline and 3-month assessments (w2=3.970, d.f.=1, n=77;
P=0.046) and between the 3-month and 6-month assessments
(w2=4.270, d.f.=1, n=74; P=0.039), but not between the 6-month
and 9-month assessments. From baseline to the 6-month assess-
ment the number of psychiatric hospitalisations was lower in
the CBT group (n=4) than in the TAU group (n=13), but this
difference was not significant. However, between the 6-month
and 9-month assessments significantly fewer people had been hos-
pitalised in the CBT group compared with the TAU group (n=1 v.
n=7; w2=6.488, d.f.=1, n=73; P=0.011).
Discussion
Main findings
The short cognitive–behavioural intervention reported here was
designed to supplement usual care following an episode of
self-harm. Our main study hypothesis, that CBT in addition to
TAU would be more effective in reducing repetition of self-harm
than TAU alone, was supported. Furthermore, those who received
CBT in addition to TAU were shown to have significantly greater
reductions in depression, anxiety and suicidal cognitions, and
significantly greater improvements in self-esteem and problem-
solving ability. It is reasonable to assume that these positive
findings are attributable to the effect of the CBT, given the random
assignment as well as the absence of between-group differences
with respect to demographic factors, number of episodes of self-
harm, history of self-harm, psychopathology and use of healthcare
services.
While this study confirms prior studies showing that self-harm
can be effectively treated by CBT,17,18 it is among the first to
suggest that these changes can occur with a brief intervention.
Furthermore, this study’s findings that time-limited CBT
decreases self-harm contrasts with the results reported by Tyrer
et al.15 The difference in outcome could be attributed to the fact
that in our study all participants who began CBT completed all
sessions, a fact that probably contributed to its efficacy. The posi-
tive treatment effect on self-harm is important given the high
suicide risk following self-harm.3 The suicidal process appears to
have been at least partially deflected by the CBT intervention.42
It is especially important that these results are found for people
with recurrent and chronic self-harm, with a high risk of
repetition and high levels of psychiatric comorbidity.
Possible mechanisms: suicidal cognitions
and behavioural skills deficits
The theoretical model underlying the cognitive–behavioural inter-
vention suggested that vulnerability to self-harm was related to
underlying suicidal cognitions and behavioural skills deficits.20
From this perspective, reduction in repetition of self-harm
following CBT might be seen as a consequence of the therapy
reducing specific suicidal thoughts and problem-solving deficits
and increasing self-esteem. As expected, over the course of treat-
ment there were marked changes in suicidal cognitions as well
as in self-esteem. The significant decrease in suicidal cognitions
is especially important, since these are considered to be the main
triggers of self-harm, especially for individuals with recurrent and
chronic self-harm.11 Given the central role of suicidal cognitions
in repetition of self-harm, the CBT aimed to increase the patient’s
208
Table 3 Multilevel analysis effects for time, condition and time6condition, and Cohen’s d effect sizes for differences on
outcome measures between the two study groups (n=82)
Variables
Time
B (s.e.)
Conditiona
B (s.e.)
Time6condition
B (s.e.)
Cohen’s d
3 months
(post-treatment)
n=40/37
Cohen’s d
6 months
(follow-up)
n=40/34
Cohen’s d
9 months
(follow-up)
n=40/33
Self-harm 70.794 (0.177)* 2.892 (2.089) 70.576 (0.241)* 0.0 0.06 0.53
Depression (BDI–II) 70.515 (0.223)* 74.047 (2.956) 71.617 (0.302)* 0.56 0.75 1.24
Anxiety (SCL–90) 70.065 (0.174) 70.748 (2.018) 71.038 (0.235)* 0.37 0.22 0.82
Suicide cognitions total (SCS) 70.835 (0.304)* 76.339 (3.661) 71.497 (0.411)* 0.64 0.67 1.03
Perceived burdensomeness (SCS) 70.106 (0.039)* 70.489 (0.465) 70.175 (0.052)* 0.49 0.56 0.88
Helplessness (SCS) 70.142 (0.089) 71.987 (1.120) 70.457 (0.132)* 0.69 0.70 1.13
Poor distress tolerance (SCS) 70.328 (0.106)* 71.797 (1.248) 70.514 (0.143)* 0.60 0.62 0.96
Unlovability (SCS) 70.268 (0.097)* 72.074 (1.168) 70.349 (0.130)* 0.54 0.56 0.88
Self-esteem (RSCQ) 0.141 (0.066)* 0.852 (0.810) 0.309 (0.089)* 0.41 0.54 0.83
BDI–II, Beck Depression Inventory II; CISS, Coping Inventory for Stressful Situations, RSCQ, Robson Self-Concept Questionnaire (short version); SCL–90, Symptom Checklist–90;
SCS, Suicide Cognitions Scale.
a. ‘Condition’ means baseline differences between the intervention and usual treatment groups.
*P50.05.
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hope by systematically targeting cognitions of perceived burden-
someness, helplessness, poor distress tolerance and unlovability.
This occurred as the therapist, while validating the patient’s
emotions, modelled hopefulness and the ability to improve the
current situation through the identification and modification of
unhelpful thoughts as well through the use of effective problem-
solving skills.
Helping patients with their current problems was another
important element of treatment, because previous research had
shown that people who self-harm display poor problem-solving
ability, which seems to be independent of mood,12 and relatively
stable unless intervened upon.43 At the start of therapy patients
commonly reported feeling overwhelmed by the problems they
were facing, believing they were lacking effective problem-solving
strategies. By identifying effective strategies that they already used,
the idea that control was already part of their repertoire was intro-
duced. In addition, patients were encouraged to develop and use
new strategies.44 As expected, patients’ problem-solving skills
significantly improved during treatment.
It is remarkable that effects on secondary measures – particu-
larly depression, suicidal cognitions and problem-solving – were
stronger than on the target variable ‘self-harm’ (the number of
episodes of self-harm in the past 3 months). Moreover, changes
in these factors seemed to precede changes in self-harm. This
suggests that the CBT primarily targeted depression, suicidal
cognitions and problem-solving and that the specific self-harm
effect (which was only apparent at the 9-month assessment) was
a secondary effect. This would be consistent with the assumption
that repetition of self-harm could be reduced by revising its main-
tenance factors.20 Given the emphasis in CBT on challenging
suicidal thinking and increasing problem-solving ability, either
of these aspects might be the mechanisms of change.
Unique additional effect of CBT
The trajectory for the average patient in the CBT group showed a
relatively rapid reduction on many outcome measures early in
therapy and this reduction continued as therapy progressed and
during the follow-up period. However, this rapid reduction is also
found in the TAU group, as indicated by the strong effect of time
in the multilevel analysis. This effect might be explained by the
fact that people were in crisis when they entered the study; at that
time their risk of self-harm was elevated, mood was particularly
low, suicidal cognitions were persistent, and these people had
great difficulty solving the problems they were facing. It has been
argued that crises are by themselves time-limited, even in those ex-
hibiting recurrent and chronic self-harm.11 However, the magni-
tude of the interaction effects in the multilevel analysis clearly
show the unique additional effect of CBT. Furthermore, cogni-
tions of helplessness and problem-solving ability did not seem
to change significantly over time in the TAU condition. Therefore,
it seems that CBT emphasises these important risk factors and
possible mediators of treatment effect. Targeting both cognitions
of helplessness and problem-solving difficulties might have made
the intervention especially effective.
Limitations
Despite these generally positive findings, several limitations of this
study deserve comment.
Assessment of self-harm
A primary limitation is that the instrument used to assess the
number of episodes of self-harm during the preceding 3 months
does not have well-established psychometric properties. Validated
instruments that cover the number of episodes of self-harm as
well as other aspects of self-harm (e.g. circumstances of the act,
motives, intent, consequences) were not available at the start of
the project.
Duration of the follow-up period
A second limitation is the absence of an extended follow-up per-
iod; a longer period could clarify whether the positive treatment
effects persist or even develop further over time. A follow-up per-
iod of 12 months would be advisable, because the risk of repeti-
tion of self-harm (and completed suicide) is at its greatest
during the first 12 months following an episode of self-harm.45
Usual treatment
A third limitation is the way in which usual treatment was speci-
fied. We recorded three forms of such treatment: psychotropic
medication, psychotherapy and psychiatric hospitalisations. We
can conclude that both conditions received a comparable level
of care within these general categories of treatment. However,
we did not record specific types of psychotherapy or psychotropic
medication in the TAU condition. Therefore, it is unclear if the
conditions were equivalent in this respect. Future studies should
record specific types of usual treatment received by people in
the experimental and comparison conditions. Furthermore, the ef-
fect of CBT was only demonstrated in relation to TAU. Therefore,
it is unclear whether the treatment effects are attributable to spe-
cific ingredients of the therapy or to the total package of CBT in
addition to TAU. Moreover, since people in the TAU group did not
always receive psychotherapy, it is conceivable that the treatment
effects in the CBT group were non-specific. In addition, more than
half of the patients in the CBT group continued with psychother-
apy or began psychotherapy after the self-harm intervention had
ended. Future research is necessary to identify variables that
mediate treatment effects (e.g. specific cognitions) and to detect
the active ingredients of the intervention therapy (e.g. identifying
and modifying suicidal cognitions).46
Recruitment and withdrawal rates
A fourth limitation is the low recruitment rate (45%) and the
relatively high rate of withdrawal from the CBT condition
(17%), in which 8 patients left prior to treatment. However,
session attendance of those who began the CBTwas high. Further-
more, other studies also report that adherence to treatment is a
well-known problem among self-harm patients, because of the
severity of their psychological distress and the wide range of
problems they face (e.g. social, financial, housing).47 Importantly,
the recruitment and withdrawal rates in this study did not exceed
rates reported in similar studies.
Treatment integrity
A fifth limitation concerns treatment integrity in the CBT condi-
tion. This could have been more systematically assessed by rating
audiotapes or videotapes of the treatment sessions. Furthermore,
the assessments were not carried out masked to treatment group,
which might have influenced outcome.
Handling of study withdrawals
A sixth limitation is the way study withdrawals were handled.
Multilevel analysis uses all available data but assumes that with-
drawals occur at random, which is questionable in this popu-
lation. As the assumption of randomness is unlikely, we also
executed and reported the results with missing data estimated
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with the LOCF method (n=90). Both this analysis (n=90) and the
analysis without the 8 withdrawals (n=82) led to a significant ef-
fect of time6condition. A significant effect of CBT for self-harm
was also observed in the ‘completers’ sample (n=73). The true
effect of the CBT is probably somewhere between the conservative
LOCF method (n=90) and the more optimistic analysis without
the 8 withdrawals (n=82). Remarkably, the LOCF method showed
the strongest effect of CBT for self-harm, which is contrary to our
expectations.
Personality disorders
A further limitation is that the presence of personality disorders
was not assessed with a structured clinical interview. The presence
of borderline personality disorder or a range of personality disor-
ders is likely to have an impact on treatment outcome. A previous
study showed that personality disturbance has an impact on
repetition of self-harm, patients with borderline personality dis-
order being most likely to repeat episodes quickly.48 Furthermore,
with the absence of data on personality disorders, it remains un-
clear whether the study population has similar Axis II diagnoses to
the patients described in the studies of Tyrer et al and Linehan et
al.15,17 However, the participants in our study strongly endorsed
maladaptive beliefs associated with personality disorders,
especially borderline and avoidant beliefs (further information
available from the authors), to a greater extent than even
patients with borderline personality disorder,49 which can be seen
as an indication of the presence of personality disturbance. The
high rate of repetition of self-harm found in this study seems to
confirm this. A last limitation is that this study primarily involved
young women with Dutch nationality. This absence of diversity
limits the generalisability of our findings.
Clinical implications
In sum, our findings extend the evidence that CBT is effective in
patients with chronic and recurrent self-harm.16,17 The results of our
study are strengthened by the consistency of the results across several
outcomes. Adding this short cognitive–behavioural intervention to
usual care might provide us with an important tool to prevent repe-
tition of self-harm in people who are at risk. It might, for instance,
be the first intervention in a stepped-care programme, in which
self-harm is addressed first, followed by a treatment focusing on
underlying personality characteristics, such as schema-focused
therapy or mentalisation-based treatment.50,51 Replication of these
findings using a longer follow-up period and more insight into the
underlying mechanisms of change is necessary.
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